| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $11,648,315 | 8 | 100 |
Sells | $0 | 0 | 0 |
| Han Yusheng | director | 8 | $11.65M | 0 | $0 | $11.65M |
Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the People's Republic of China. Its operations are structured across three key segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company leverages next-generation sequencing (NGS) technology to offer a diverse portfolio of tests designed to guide therapeutic decisions and predict prognoses for …
Over the last 12 months, insiders at Burning Rock Biotech Limited have bought $11.65M and sold $0 worth of Burning Rock Biotech Limited stock.
On average, over the past 5 years, insiders at Burning Rock Biotech Limited have bought $11.65M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Han Yusheng (director) — $11.65M.
The last purchase of 24,900 shares for transaction amount of $199,090 was made by Han Yusheng (director) on 2026‑06‑26.
| 2026-06-26 | Han Yusheng | director | 24,900 2.2776% | $8.00 | $199,090 | +30.17% | ||
| 2026-06-24 | Han Yusheng | director | 250,000 25.0285% | $8.00 | $2M | +25.94% | ||
| 2026-06-23 | Han Yusheng | director | 5,990 0.5621% | $7.50 | $44,920 | +41.67% | ||
| 2026-06-22 | Han Yusheng | director | 104,650 9.5425% | $7.45 | $779,674 | +38.23% | ||
| 2026-06-16 | Han Yusheng | director | 111,110 11.6364% | $9.00 | $999,957 | +28.41% | ||
| 2026-06-12 | Han Yusheng | director | 210,000 21.2686% | $9.25 | $1.94M | +21.30% | ||
| 2026-06-11 | Han Yusheng | director | 24,760 2.3053% | $8.74 | $216,388 | +17.50% | ||
| 2026-03-31 | Han Yusheng | director | 314,870 31.4752% | $17.36 | $5.47M | -27.77% |
| Increased Positions | 7 | +36.84% | 309,408 | +21.62% |
| Decreased Positions | 7 | -36.84% | 30,161 | -2.11% |
| New Positions | 3 | New | 30,927 | New |
| Sold Out Positions | 3 | Sold Out | 13,064 | Sold Out |
| Total Postitions | 19 | 0% | 2M | +19.51% |